DREAM Challenges

DREAM 9 Acute Myeloid Leukemia (AML) Outcome Prediction

DREAM 9 Acute Myeloid Leukemia (AML) Outcome Prediction

JUNE 2, 2014 – SEPTEMBER 15, 2014

Predict the outcome of treatment of AML patients (resistant or remission), their remission duration and overall survival based on clinical cytogentics, known genetics markers and phosphoproteomic data.